An Open-Label, Single-Dose Study to Assess the Pharmacokinetics, Safety, and Tolerability of Oral BG9928 in Subjects With Mild and Moderate Hepatic Impairment and in Healthy Subjects
Phase of Trial: Phase I
Latest Information Update: 05 Jun 2015
At a glance
- Drugs Tonapofylline (Primary)
- Indications Acute heart failure; Chronic heart failure
- Focus Pharmacokinetics
- Sponsors Biogen Idec
- 24 Dec 2009 Actual end date (Jul 2009) added as reported by ClinicalTrials.gov.
- 24 Dec 2009 Actual patient number (23) added as reported by ClinicalTrials.gov.
- 24 Dec 2009 Status changed from not yet recruiting to completed as reported by ClinicalTrials.gov.